|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 474.80 GBX | +0.25% |
|
+2.24% | +0.49% |
| 05-18 | Tate & Lyle cut; Morgan Stanley raises Burberry | AN |
| 05-14 | Multiconsult to Provide Multidisciplinary Technical Services for Chemring Nobel Project in Norway | MT |
| Fiscal Period: October | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.97 | 6 | 7.16 | 5.98 | 5.84 | |||||
Return on Total Capital | 8.23 | 8.33 | 10.32 | 9.02 | 9.17 | |||||
Return On Equity % | 12.16 | 12.3 | 9.47 | 11.62 | 14.44 | |||||
Return on Common Equity | 12.16 | 12.3 | 9.47 | 11.62 | 14.44 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 100 | 100 | 100 | 67.36 | 66.95 | |||||
SG&A Margin | 0.03 | 0.02 | 0.13 | 38.42 | 40.86 | |||||
EBITDA Margin % | 18.89 | 17.28 | 19.02 | 16.26 | 19.08 | |||||
EBITA Margin % | 14.62 | 13.55 | 15.38 | 12.52 | 14.95 | |||||
EBIT Margin % | 13.02 | 12.49 | 14.75 | 12.07 | 14.61 | |||||
Income From Continuing Operations Margin % | 10.55 | 10.7 | 7.98 | 8.37 | 10.71 | |||||
Net Income Margin % | 10.55 | 10.7 | 1.14 | 7.74 | 9.69 | |||||
Net Avail. For Common Margin % | 10.55 | 10.7 | 7.98 | 8.37 | 10.71 | |||||
Normalized Net Income Margin | 8.02 | 7.33 | 8.77 | 6.92 | 8.32 | |||||
Levered Free Cash Flow Margin | 8.61 | 4.65 | 11.05 | -2.39 | -9.11 | |||||
Unlevered Free Cash Flow Margin | 8.85 | 4.85 | 11.14 | -1.8 | -8.39 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.73 | 0.77 | 0.78 | 0.79 | 0.64 | |||||
Fixed Assets Turnover | 2 | 2.06 | 2 | 1.93 | 1.55 | |||||
Receivables Turnover (Average Receivables) | 7.4 | 9.26 | 12.67 | 11.68 | 9.46 | |||||
Inventory Turnover (Average Inventory) | - | - | - | 1.46 | 1.22 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.44 | 1.59 | 1.29 | 1.22 | 1.65 | |||||
Quick Ratio | 0.59 | 0.64 | 0.51 | 0.58 | 0.78 | |||||
Operating Cash Flow to Current Liabilities | 0.74 | 0.71 | 0.46 | 0.37 | 0.45 | |||||
Days Sales Outstanding (Average Receivables) | 49.33 | 39.4 | 28.81 | 31.34 | 38.59 | |||||
Days Outstanding Inventory (Average Inventory) | - | - | - | 251.32 | 300.06 | |||||
Average Days Payable Outstanding | - | - | - | 42.13 | 51.77 | |||||
Cash Conversion Cycle (Average Days) | - | - | - | 240.53 | 286.88 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 9.18 | 6.46 | 5.5 | 27.45 | 40.42 | |||||
Total Debt / Total Capital | 8.41 | 6.07 | 5.21 | 21.54 | 28.78 | |||||
LT Debt/Equity | 8.67 | 6.03 | 5.2 | 14.79 | 27.25 | |||||
Long-Term Debt / Total Capital | 7.94 | 5.66 | 4.93 | 11.61 | 19.41 | |||||
Total Liabilities / Total Assets | 33.62 | 32.58 | 36.54 | 48.52 | 55.74 | |||||
EBIT / Interest Expense | 34.13 | 39.5 | 99.57 | 12.83 | 12.75 | |||||
EBITDA / Interest Expense | 50.47 | 55.79 | 130.43 | 17.69 | 17.05 | |||||
(EBITDA - Capex) / Interest Expense | 31.8 | 33.29 | 83.71 | 4.19 | 0.67 | |||||
Total Debt / EBITDA | 0.43 | 0.35 | 0.23 | 1.15 | 1.59 | |||||
Net Debt / EBITDA | 0.35 | 0.09 | 0.16 | 0.62 | 0.92 | |||||
Total Debt / (EBITDA - Capex) | 0.68 | 0.58 | 0.35 | 4.87 | 40.63 | |||||
Net Debt / (EBITDA - Capex) | 0.56 | 0.15 | 0.25 | 2.63 | 23.45 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -2.29 | 12.59 | 17.86 | 8 | 1.88 | |||||
Gross Profit, 1 Yr. Growth % | -2.29 | 12.59 | 17.86 | 5.65 | 1.37 | |||||
EBITDA, 1 Yr. Growth % | 0.68 | 2.96 | 25.03 | -10.46 | 4.98 | |||||
EBITA, 1 Yr. Growth % | 1.05 | 4.35 | 31.23 | -15.7 | 3.48 | |||||
EBIT, 1 Yr. Growth % | 6.67 | 8.01 | 35.6 | -15.38 | 4.45 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 19.6 | 14.22 | -15.09 | 13.26 | 28.43 | |||||
Net Income, 1 Yr. Growth % | 19.6 | 14.22 | -88.61 | 631.48 | 22.03 | |||||
Normalized Net Income, 1 Yr. Growth % | 15.83 | 2.77 | 38.12 | -18.71 | 2.64 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 20 | 13.89 | -14.94 | 16.79 | 29.53 | |||||
Accounts Receivable, 1 Yr. Growth % | -8.12 | -12.18 | 24.02 | 11.62 | 28.2 | |||||
Inventory, 1 Yr. Growth % | -11.61 | 23.42 | 2.11 | 24.98 | 12.67 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.42 | 16.41 | 4.71 | 18.83 | 23.25 | |||||
Total Assets, 1 Yr. Growth % | -1.83 | 16.67 | -3.82 | 16.05 | 24.71 | |||||
Tangible Book Value, 1 Yr. Growth % | 12.47 | 25.48 | -7 | -7.68 | -3.67 | |||||
Common Equity, 1 Yr. Growth % | 7.04 | 18.51 | -9.47 | -5.87 | 7.21 | |||||
Cash From Operations, 1 Yr. Growth % | -0.26 | 6.34 | -18.14 | 22.91 | 12.47 | |||||
Capital Expenditures, 1 Yr. Growth % | -21.35 | 12.5 | 3.81 | 98.17 | 44.14 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -3.77 | -39.2 | 189.34 | -122.52 | -23.82 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -5.95 | -38.33 | 178.27 | -116.85 | -26.08 | |||||
Dividend Per Share, 1 Yr. Growth % | 23.08 | 18.75 | 21.05 | 13.04 | 2.56 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.32 | 4.89 | 9.62 | 12.82 | 2.6 | |||||
Gross Profit, 2 Yr. CAGR % | 27.3 | 4.89 | 9.62 | -7.41 | 1.18 | |||||
EBITDA, 2 Yr. CAGR % | 10.91 | 1.81 | 10 | 7.44 | 1.18 | |||||
EBITA, 2 Yr. CAGR % | 13.54 | 2.69 | 12.44 | 7.4 | -0.93 | |||||
EBIT, 2 Yr. CAGR % | 25.71 | 7.34 | 16.68 | 9.47 | -0.07 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 34.03 | 16.88 | -4.69 | -1.93 | 18.9 | |||||
Net Income, 2 Yr. CAGR % | 37.66 | 16.88 | -63.93 | -8.71 | 198.76 | |||||
Normalized Net Income, 2 Yr. CAGR % | 35.76 | 9.1 | 14.58 | 8.49 | -2.4 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 33.33 | 16.9 | -4.62 | -0.33 | 21.38 | |||||
Accounts Receivable, 2 Yr. CAGR % | 29.61 | -10.17 | -9.92 | 17.66 | 19.62 | |||||
Inventory, 2 Yr. CAGR % | 1.65 | 4.45 | 12.26 | 12.96 | 18.66 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.11 | 9.19 | 10.4 | 11.55 | 21.02 | |||||
Total Assets, 2 Yr. CAGR % | 3.28 | 7.02 | 5.93 | 5.65 | 20.3 | |||||
Tangible Book Value, 2 Yr. CAGR % | 15.64 | 18.8 | 8.03 | -7.34 | -5.7 | |||||
Common Equity, 2 Yr. CAGR % | 7.41 | 12.63 | 3.58 | -7.69 | 0.46 | |||||
Cash From Operations, 2 Yr. CAGR % | 10.59 | 2.99 | -6.7 | 0.31 | 17.58 | |||||
Capital Expenditures, 2 Yr. CAGR % | -17.36 | -5.93 | 8.07 | 43.43 | 69 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 32.98 | -23.51 | 24.19 | -17.79 | -8.52 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 25.34 | -23.84 | 23.02 | -30.28 | -12.54 | |||||
Dividend Per Share, 2 Yr. CAGR % | 15.47 | 20.89 | 19.9 | 16.98 | 7.68 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 9.76 | 9.72 | 5.5 | 9.08 | 7.45 | |||||
Gross Profit, 3 Yr. CAGR % | 22.51 | 22.19 | 5.5 | -4.38 | -6 | |||||
EBITDA, 3 Yr. CAGR % | 91.98 | 8.2 | 6.8 | 3.76 | 9.69 | |||||
EBITA, 3 Yr. CAGR % | 128.81 | 10.39 | 8.51 | 3.58 | 10.33 | |||||
EBIT, 3 Yr. CAGR % | 45.86 | 19.51 | 13.24 | 6.36 | 12.25 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 0.57 | 27.07 | 2.8 | 0.95 | 6.28 | |||||
Net Income, 3 Yr. CAGR % | -26.8 | 29.35 | -46.21 | -1.63 | 0.56 | |||||
Normalized Net Income, 3 Yr. CAGR % | 32.32 | 23.73 | 14.99 | 3.81 | 11.31 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -0.46 | 26.51 | 2.97 | 2.04 | 7.81 | |||||
Accounts Receivable, 3 Yr. CAGR % | 3.89 | 13.84 | -9.33 | -3.25 | 21.07 | |||||
Inventory, 3 Yr. CAGR % | 4.17 | 8.44 | 3.66 | 16.35 | 12.87 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 10.29 | 10.81 | 7.68 | 13.14 | 15.32 | |||||
Total Assets, 3 Yr. CAGR % | -1.15 | 7.56 | 3.28 | 9.2 | 11.65 | |||||
Tangible Book Value, 3 Yr. CAGR % | 15.99 | 18.83 | 9.49 | 2.52 | -6.13 | |||||
Common Equity, 3 Yr. CAGR % | 6.24 | 10.99 | 4.72 | 0.33 | -2.97 | |||||
Cash From Operations, 3 Yr. CAGR % | 28.23 | 9.15 | -4.6 | 2.28 | 4.21 | |||||
Capital Expenditures, 3 Yr. CAGR % | 14.2 | -8.41 | -2.79 | 32.27 | 43.66 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 8.88 | 2.44 | 14.07 | -28.84 | 35.92 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 5.09 | -1.05 | 12.49 | -35.82 | 30.19 | |||||
Dividend Per Share, 3 Yr. CAGR % | 13.3 | 16.55 | 20.95 | 17.57 | 11.96 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -3.79 | 7.59 | 9.71 | 8.77 | 4.33 | |||||
Gross Profit, 5 Yr. CAGR % | 8.2 | 16.63 | 17.18 | 7.21 | -3.71 | |||||
EBITDA, 5 Yr. CAGR % | 1.29 | 17.47 | 53.64 | 6.56 | 5.16 | |||||
EBITA, 5 Yr. CAGR % | 2.31 | 27.51 | 72.21 | 7.46 | 5.51 | |||||
EBIT, 5 Yr. CAGR % | 7.06 | 58.09 | 33.4 | 13.71 | 8.66 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 44.89 | 61.61 | -1.57 | 13.07 | 8.96 | |||||
Net Income, 5 Yr. CAGR % | 30.18 | 48.34 | -44.85 | 12.52 | 6.79 | |||||
Normalized Net Income, 5 Yr. CAGR % | 22.38 | 51.51 | 24.91 | 15.57 | 8.71 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 43.1 | 60.5 | -2.14 | 13.56 | 9.97 | |||||
Accounts Receivable, 5 Yr. CAGR % | -9.73 | -13.57 | -1.88 | 8.76 | 1.3 | |||||
Inventory, 5 Yr. CAGR % | -5.09 | 0.41 | 7.33 | 10.23 | 9.42 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 2.01 | 7.64 | 10.34 | 11.1 | 12.83 | |||||
Total Assets, 5 Yr. CAGR % | -7.22 | -2.45 | 1.63 | 6.79 | 9.78 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.49 | 5.69 | 12.73 | 7.58 | 3.14 | |||||
Common Equity, 5 Yr. CAGR % | -3.12 | 0.83 | 5.17 | 3.1 | 2.99 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.03 | 20.11 | 12.92 | 5.53 | 3.72 | |||||
Capital Expenditures, 5 Yr. CAGR % | 22.14 | 20.11 | 11.71 | 9.59 | 21.28 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 17.39 | 6.84 | 14.76 | -8.62 | 5.19 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 7.94 | -0.13 | 11.92 | -16.12 | 2.45 | |||||
Dividend Per Share, 5 Yr. CAGR % | 29.86 | 13.7 | 15.9 | 16.72 | 15.45 |
- Stock Market
- Equities
- CHG Stock
- Financials Chemring Group PLC
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















